Nex­Im­mune to lay off 53% of em­ploy­ees to save mon­ey, CFO to step down 

Im­munother­a­py com­pa­ny Nex­Im­mune plans to lay off 22 of its 47 em­ploy­ees by Sep. 5 to re­duce the com­pa­ny’s ex­pens­es. John Train­er is va­cat­ing his role as CFO from Sep. 2 but will stay on as a con­sul­tant and ad­vi­sor. He joined Nex­Im­mune in Jan. 2020.

As of June 30, the com­pa­ny had $16.3 mil­lion in cash and cash equiv­a­lents, which is a drop from $34.6 mil­lion at the end of 2022, as per the com­pa­ny’s sec­ond quar­ter earn­ings re­port re­leased on Aug. 10. The com­pa­ny said then that its funds should be enough to tide the com­pa­ny in­to the fourth quar­ter.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER